Clinical and prognostic significance of matrix metalloproteinase-7 and vascular endothelium growth factor in patients with ovarian cancer
- 作者: Knyazev R1, Poddubnaya I1, Bokin I1, Barinov V2
-
隶属关系:
- Russian Medical Academy of Postgraduate Education of the Ministry of Health of the Russian
- N.N.Blokhin Russian Cancer Research Center
- 期: 卷 17, 编号 3 (2015)
- 页面: 76-80
- 栏目: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/27033
- ID: 27033
如何引用文章
全文:
详细
作者简介
R Knyazev
Russian Medical Academy of Postgraduate Education of the Ministry of Health of the Russian
Email: sluwba@mail.ru
аспирант каф. онкологии ГБОУ ДПО РМАПО 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
I Poddubnaya
Russian Medical Academy of Postgraduate Education of the Ministry of Health of the Russianд-р мед. наук, проф., чл.-корр. РАН, зав. каф. онкологии ГБОУ ДПО РМАПО 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
I Bokin
Russian Medical Academy of Postgraduate Education of the Ministry of Health of the Russianканд. мед. наук, ассистент каф. онкологии ГБОУ ДПО РМАПО 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1
V Barinov
N.N.Blokhin Russian Cancer Research Centerд-р мед. наук, проф., вед. науч. сотр. отд-ния гинекологии ФГБУ РОНЦ им. Н.Н.Блохина 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23
参考
- International agency for research on cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx
- Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2013 году (заболеваемость и смертность). М.: МНИОИ им. П.А.Герцена, 2015.
- Moss L.A.S, Jensen-Taubman S, Stetler-Stevenson W.G. Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol 2012; 181 (6): 1895-9.
- Liotta L.A et al. Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 1986; 46 (1): 1-7.
- Герштейн Е.С., Кушлинский Н.Е. Клинические перспективы исследования ассоциированных с опухолью протеаз и их тканевых ингибиторов у онкологических больных. Вестн. РАМН. 2013; 5: 16-27.
- Wang F et al. Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int J Cancer 2005; 114 (1): 19-31.
- Zohny S.F, Fayed S.T. Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer. Med Oncol 2010; 27 (4): 1246-53.
- Schummer M et al. Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125. Gynecol Oncol 2012; 125 (1): 65-9.
- Wang H et al. The expression of VEGF and Dll4/Notch pathway molecules in ovarian cancer. Clinica Chimica Acta 2014; 436: 243-8.
- He L, He J, Zhao X. Expression of VEGF-D in epithelial ovarian cancer and its relationship to lymphatic metastasis. Asia-Pacific J Clinical Oncol 2013.
- Левкина Н.В. Клиническое значение матриксных металлопротеиназ у больных раком яичников. Дис. … канд. мед. наук. М., 2011.
- Acar A et al. Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer. Med Oncol 2008; 25 (3): 279-83.
- Cheng D, Liang B, Li Y. Serum vascular endothelial growth factor (VEGF-C) as a diagnostic and prognostic marker in patients with ovarian cancer. PloS One 2013; 8 (2): e55309.
- Herr D et al. VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5. Gynecol Oncol 2012; 127 (1): 210-6.
- Liang B et al. Elevated VEGF concentrations in ascites and serum predict adverse prognosis in ovarian cancer. Scand J Clin Lab Investig 2013; 73 (4): 309-14.
- Brun J.L et al. Serous and mucinous ovarian tumors express different profiles of MMP-2,-7,-9, MT1-MMP, and TIMP-1 and-2. Int J Oncol 2008; 33 (6): 1239-46.
- Sillanpää S.M et al. Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to b - catenin expression. Int J Cancer 2006; 119 (8): 1792-9.